Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial

Yunpeng Yang, Jianya Zhou, Jianying Zhou, Jifeng Feng, Wu Zhuang, Jianhua Chen, Jun Zhao, Wei Zhong, Yanqiu Zhao, Yiping Zhang, Yong Song, Yi Hu, Zhuang Yu, Youling Gong, Yuan Chen, Feng Ye, Shucai Zhang, Lejie Cao, Yun Fan, Gang Wu, Yubiao Guo, Chengzhi Zhou, Kewei Ma, Jian Fang, Weineng Feng, Yunpeng Liu, Zhendong Zheng, Gaofeng Li, Ning Wu, Wei Song, Xiaoqing Liu, Shijun Zhao, Lieming Ding, Li Mao, Giovanni Selvaggi, Xiaobin Yuan, Yuanqing Fu, Tao Wang, Shanshan Xiao, Li ZhangThe Lancet Respiratory Medicine 2019 · DOI

BibTeX
@inproceedings{yang2019efficacy,
  author = {Yunpeng Yang and Jianya Zhou and Jianying Zhou and Jifeng Feng and Wu Zhuang and Jianhua Chen and Jun Zhao and Wei Zhong and Yanqiu Zhao and Yiping Zhang and Yong Song and Yi Hu and Zhuang Yu and Youling Gong and Yuan Chen and Feng Ye and Shucai Zhang and Lejie Cao and Yun Fan and Gang Wu and Yubiao Guo and Chengzhi Zhou and Kewei Ma and Jian Fang and Weineng Feng and Yunpeng Liu and Zhendong Zheng and Gaofeng Li and Ning Wu and Wei Song and Xiaoqing Liu and Shijun Zhao and Lieming Ding and Li Mao and Giovanni Selvaggi and Xiaobin Yuan and Yuanqing Fu and Tao Wang and Shanshan Xiao and Li Zhang},
  title = {{Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial}},
  booktitle = {The Lancet Respiratory Medicine},
  year = {2019},
  doi = {10.1016/s2213-2600(19)30252-8},
}

Loading related content...

Figure